Quantcast

Latest Oncology Stories

2014-07-25 10:41:50

Temple University Health System Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine. The study, published online by JAMA Dermatology on July 23, 2014, found that nearly 36. 9 percent of skin cancer lesions are accompanied by itching, while 28.2 percent involve pain....

2014-07-25 08:26:13

SUNNYVALE, Calif., July 25, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA(®) (ibrutinib) in the European Union. IMBRUVICA is being jointly developed and commercialized in the United States by Pharmacyclics and Janssen Biotech, Inc. In Europe, once approved,...

2014-07-25 08:25:15

Phase I studies start in 2015 NEW HAVEN, Conn., July 25, 2014 /PRNewswire/ -- Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd. (ASX; NRT: NASDAQ; NVGN), today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil(TM). CanTx and Novogen expect to file an Investigational New Drug (IND) application for Cantrixil early next year and to advance this compound...

2014-07-25 08:24:56

LUGANO, Switzerland, July 25, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to cancer patients and doctors. (Logo: http://photos.prnewswire.com/prnh/20131128/654773 ) The proposed wording -'explicit and specific patient consent' - implies that researchers would have to approach patients and ask...

2014-07-24 23:05:03

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. Bethesda, MD (PRWEB) July 24, 2014 The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an...

2014-07-24 08:34:35

WASHINGTON, July 24, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain with one call to 866-714-6466 this can be a gigantic mistake for the victim, or their family members. According to the CDC the average of a diagnosed victim of mesothelioma is 72 years old. http://MesotheliomaCompensationCenter.Com...

2014-07-23 23:29:47

The Mesothelioma Compensation Center is urging the family members of a diagnosed victim of this rare form of cancer to call them at 866-714-6466 for information on the best possible compensation. This week the group is offering to create a comprehensive “must do” checklist that covers all of the bases for the victim and their family members that includes treatment options. http://MesotheliiomaCompensationCenter.Com (PRWEB) July 22, 2014 The Mesothelioma Compensation Center is urging...

2014-07-23 23:23:34

LIVESTRONG houses PAF representative in its Cancer Navigation Center. Austin, Texas (PRWEB) July 22, 2014 For the past nine years, the LIVESTRONG Foundation and Patient Advocate Foundation (PAF) have been working in tandem to help thousands of cancer patients and survivors understand their insurance options, facilitate access to care, and help survivors connect to resources dealing with work discrimination issues. In 2014, the two foundations expanded their partnership to include...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

2014-07-23 23:05:38

The Circuelle Foundation wants women to know leading researchers believe breast self-exams make a significant impact in detecting breast cancer. SARASOTA, Fla. (PRWEB) July 23, 2014 The Circuelle Foundation compiled and released independent research results from leading academic institutions uncovering the importance of breast self-exams (BSE). The historical events and opinions surrounding the need for breast self-exams is contradictory and can be confusing at best, but there is proof...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related